Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Gene Expression Profiling in Short-Term Imbibition of Wheat: Tools for Dissecting of Pasting Properties of Imbibed Wheat Seeds.

Tamura T, Akuzawa S, Mura K.

J Food Sci. 2019 May;84(5):946-953. doi: 10.1111/1750-3841.14471. Epub 2019 Apr 4.

PMID:
30947368
2.

[Treatment of Mediastinitis after Open Heart Surgery Using Negative Pressure Wound Therapy with Irrigation].

Suzuki K, Ishigami N, Akuzawa S.

Kyobu Geka. 2018 Oct;71(11):916-918. Japanese.

PMID:
30310001
3.

Draft Genome Sequence of Bacillus licheniformis Heshi-B2, Isolated from Fermented Rice Bran in a Japanese Fermented Seafood Dish.

Kanesaki Y, Kubota E, Ohtake R, Higashi Y, Nagaoka J, Suzuki T, Akuzawa S.

Genome Announc. 2018 Mar 8;6(10). pii: e00118-18. doi: 10.1128/genomeA.00118-18.

4.

A comparison of the effects of heat moisture treatment (HMT) on rheological properties and amylopectin structure in sago (Metroxylon sago) and arenga (Arenga pinnata) starches.

Adawiyah DR, Akuzawa S, Sasaki T, Kohyama K.

J Food Sci Technol. 2017 Oct;54(11):3404-3410. doi: 10.1007/s13197-017-2787-1. Epub 2017 Sep 13.

5.

GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the Fmr1 Knockout Mouse Model of Fragile X Syndrome.

Sinclair D, Featherstone R, Naschek M, Nam J, Du A, Wright S, Pance K, Melnychenko O, Weger R, Akuzawa S, Matsumoto M, Siegel SJ.

eNeuro. 2017 Mar 1;4(1). pii: ENEURO.0380-16.2017. doi: 10.1523/ENEURO.0380-16.2017. eCollection 2017 Jan-Feb.

6.

Draft Genome Sequence of Paenibacillus amylolyticus Heshi-A3, Isolated from Fermented Rice Bran in a Japanese Fermented Seafood Dish.

Akuzawa S, Nagaoka J, Kanekatsu M, Kubota E, Ohtake R, Suzuki T, Kanesaki Y.

Genome Announc. 2016 Mar 31;4(2). pii: e00218-16. doi: 10.1128/genomeA.00218-16.

7.

Draft Genome Sequence of Oceanobacillus picturae Heshi-B3, Isolated from Fermented Rice Bran in a Traditional Japanese Seafood Dish.

Akuzawa S, Nagaoka J, Kanekatsu M, Kanesaki Y, Suzuki T.

Genome Announc. 2016 Feb 4;4(1). pii: e01621-15. doi: 10.1128/genomeA.01621-15.

8.

Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists.

Moritomo A, Yamada H, Matsuzawa-Nomura T, Watanabe T, Itahana H, Oku M, Akuzawa S, Okada M.

Bioorg Med Chem. 2014 Nov 1;22(21):6026-38. doi: 10.1016/j.bmc.2014.09.005. Epub 2014 Sep 16.

PMID:
25281269
9.

Inactivation of Kudoa septempunctata in olive flounder meat by liquid freezing.

Ohnishi T, Akuzawa S, Furusawa H, Yoshinari T, Kamata Y, Sugita-Konishi Y.

Biocontrol Sci. 2014;19(3):135-8.

10.

Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.

Moritomo A, Yamada H, Watanabe T, Itahana H, Koga Y, Akuzawa S, Okada M.

Bioorg Med Chem. 2014 Aug 1;22(15):4323-37. doi: 10.1016/j.bmc.2014.05.027. Epub 2014 May 28.

PMID:
24916029
11.

Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.

Moritomo A, Yamada H, Watanabe T, Itahana H, Akuzawa S, Okada M, Ohta M.

Bioorg Med Chem. 2013 Dec 15;21(24):7841-52. doi: 10.1016/j.bmc.2013.10.010. Epub 2013 Oct 21.

PMID:
24189186
12.

Surgical treatment of papillary fibroelastoma in the aortic valve: a case report.

Washiyama N, Yamashita K, Terada H, Ohkura K, Akuzawa S.

Ann Thorac Cardiovasc Surg. 2010 Aug;16(4):297-300.

PMID:
21057452
13.

Congenital systemic and coronary-to-pulmonary artery fistulas.

Ohkura K, Yamashita K, Terada H, Washiyama N, Akuzawa S.

Ann Thorac Cardiovasc Surg. 2010 Jun;16(3):203-6.

PMID:
20930684
14.

Intrathecal injection of hepatocyte growth factor gene-modified marrow stromal cells attenuates neurologic injury induced by transient spinal cord ischemia in rabbits.

Shi E, Jiang X, Wang L, Akuzawa S, Nakajima Y, Kazui T.

Anesthesiology. 2010 Nov;113(5):1109-17. doi: 10.1097/ALN.0b013e3181f6970d.

PMID:
20930612
15.

[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].

Hirata T, Funatsu T, Keto Y, Akuzawa S, Akiho H, Nishida A, Sasamata M, Miyata K.

Nihon Yakurigaku Zasshi. 2009 May;133(5):281-91. Review. Japanese. No abstract available.

PMID:
19443966
16.

Characterization of pullulanase (PUL)-deficient mutants of rice (Oryza sativa L.) and the function of PUL on starch biosynthesis in the developing rice endosperm.

Fujita N, Toyosawa Y, Utsumi Y, Higuchi T, Hanashiro I, Ikegami A, Akuzawa S, Yoshida M, Mori A, Inomata K, Itoh R, Miyao A, Hirochika H, Satoh H, Nakamura Y.

J Exp Bot. 2009;60(3):1009-23. doi: 10.1093/jxb/ern349. Epub 2009 Feb 3.

17.

Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits.

Akuzawa S, Kazui T, Shi E, Yamashita K, Bashar AH, Terada H.

J Vasc Surg. 2008 Sep;48(3):694-700. doi: 10.1016/j.jvs.2008.04.011. Epub 2008 Jun 24.

18.

Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.

Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.

Eur J Pharmacol. 2008 Jun 10;587(1-3):281-4. doi: 10.1016/j.ejphar.2008.03.040. Epub 2008 Mar 30.

PMID:
18456254
20.

Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.

Hirata T, Keto Y, Nakata M, Takeuchi A, Funatsu T, Akuzawa S, Sasamata M, Miyata K.

Neurogastroenterol Motil. 2008 May;20(5):557-65. doi: 10.1111/j.1365-2982.2007.01069.x. Epub 2008 Jan 21.

PMID:
18221252
21.

Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.

Funatsu T, Takeuchi A, Hirata T, Keto Y, Akuzawa S, Sasamata M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):190-5. Epub 2007 Jul 3.

PMID:
17658508
22.

Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.

Hirata T, Keto Y, Funatsu T, Akuzawa S, Sasamata M.

J Pharmacol Sci. 2007 Jul;104(3):263-73.

23.

Effect of prophylactically administered edaravone during antegrade cerebral perfusion in a canine model of old cerebral infarction.

Suzuki T, Kazui T, Yamamoto S, Washiyama N, Ohkura K, Ohishi K, Bashar AH, Yamashita K, Terada H, Suzuki K, Akuzawa S, Fujie M.

J Thorac Cardiovasc Surg. 2007 Mar;133(3):710-6.

24.

New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation.

Imanishi N, Iwaoka K, Koshio H, Nagashima SY, Kazuta K, Ohta M, Sakamoto S, Ito H, Akuzawa S, Kiso T, Tsukamoto S, Mase T.

Bioorg Med Chem. 2003 Apr 3;11(7):1493-502.

PMID:
12628674
25.

Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.

Ito H, Kiso T, Miyata K, Kamato T, Yuki H, Akuzawa S, Nagakura Y, Yamano M, Suzuki M, Naitoh Y, Sakai H, Iwaoka K, Yamaguchi T.

Eur J Pharmacol. 2000 Dec 8;409(2):195-201.

PMID:
11104834
26.

Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.

Nagakura Y, Akuzawa S, Miyata K, Kamato T, Suzuki T, Ito H, Yamaguchi T.

Pharmacol Res. 1999 May;39(5):375-82.

PMID:
10328995
27.
28.

Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.

Takemoto Y, Yuki H, Nishida A, Ito H, Kobayashi-Uchida A, Takinami Y, Akuzawa S, Ohta M, Satoh M, Semple G, Miyata K.

Arzneimittelforschung. 1998 Apr;48(4):403-7.

PMID:
9608884
29.

YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.

Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K.

Dig Dis Sci. 1997 Apr;42(4):707-14.

PMID:
9125636
30.

YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.

Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.

Aliment Pharmacol Ther. 1997 Feb;11(1):113-20.

31.

(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.

Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.

J Med Chem. 1997 Jan 31;40(3):331-41.

PMID:
9022799
32.
33.

Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.

Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.

Chem Pharm Bull (Tokyo). 1996 Jul;44(7):1412-4.

PMID:
8706146
34.

Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.

Akuzawa S, Miyake A, Miyata K, Fukutomi H.

Eur J Pharmacol. 1996 Jan 25;296(2):227-30.

PMID:
8838461
36.

Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.

Nishida A, Kobayashi-Uchida A, Akuzawa S, Takinami Y, Shishido T, Kamato T, Ito H, Yamano M, Yuki H, Nagakura Y, et al.

Am J Physiol. 1995 Nov;269(5 Pt 1):G699-705.

PMID:
7491961
37.

Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.

Miyake A, Mochizuki S, Takemoto Y, Akuzawa S.

Mol Pharmacol. 1995 Sep;48(3):407-16.

PMID:
7565620
38.

Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.

Akuzawa S, Miyata K, Fukutomi H.

Eur J Pharmacol. 1995 Jul 25;281(1):37-42.

PMID:
8566114
39.

Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.

Ito H, Akuzawa S, Tsutsumi R, Kiso T, Kamato T, Nishida A, Yamano M, Miyata K.

Neuropharmacology. 1995 Jun;34(6):631-7.

PMID:
7566499
40.
41.

Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y, et al.

J Pharmacol Exp Ther. 1994 May;269(2):725-31.

PMID:
7910212
42.

Hepatic accumulation and hepatotoxicity of luteoskyrin in mice.

Masuda T, Ito J, Akuzawa S, Ishii K, Takagi H, Ueno Y.

Toxicol Lett. 1992 Jun;61(1):9-20.

PMID:
1609444
43.

Radical-mediated modification of deoxyguanine and deoxyribose by luteoskyrin and related anthraquinones.

Akuzawa S, Yamaguchi H, Masuda T, Ueno Y.

Mutat Res. 1992 Apr;266(2):63-9.

PMID:
1373839
44.

Spinnability of Starch Pastes.

Akuzawa S, Sawayama S, Kawabata A.

Biosci Biotechnol Biochem. 1992 Jan;56(6):932-6. doi: 10.1271/bbb.56.932.

Supplemental Content

Loading ...
Support Center